AMSilk is the world's first industrial supplier of smart biotech materials with current scale-up phase by applying an outstanding technology protein platform based on silk proteins for a variety of applications such as textile fibers, medical devices and consumer goods.
AMSilk has raised €77M across 2 funding rounds from 6 investors, most recently a round in Sep 2025. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-09-09 | Other | €52M | ATHOS CAPITAL,MIG Capital,Novo Holdings | View deal → |
| 2023-04-04 | Series C | €25M | Athos Capital,Cargill,MIG Capital,MIG Funds,Novo Holdings | View deal → |